companydata.dkReshape ApS: Financial statements 2022
CVR: 40056173
Reshape ApS (CVR 40056173) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -118,187 and a net result of DKK -1,649,207 compared with DKK 52,283 the year before. Equity amounted to DKK 5,534,016. The solvency ratio was 90.1%. The company had 16 employees in the financial year.
- Gross Profit
- -118,187 kr.
- Profit/Loss
- -1,649,207 kr.
- Equity
- 5,534,016 kr.
- Total Assets
- 6,139,831 kr.
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
| 2021 | - | 593 t. | 52 t. | 1.3 mio. | 7 |
Keep an eye on Reshape ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 18, 2022, Nicholas Peter Francis has left the board of directors of Reshape ApS.
As of November 18, 2022, Magnus Nyborg Madsen has left the board of directors of Reshape ApS.
As of November 18, 2022, Lars Holger Dalgaard Andersen has left the board of directors of Reshape ApS.
As of November 18, 2022, Daniel Storgaard has left the board of directors of Reshape ApS.
As of November 18, 2022, Carl-Emil Grøn Fuglesang has left the board of directors of Reshape ApS.
About Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Magnus Nyborg Madsen, Daniel Storgaard and Carl-Emil Grøn Fuglesang. The company is owned by Reshape Biotech Inc.. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity amounted to DKK 75,515,117.